SCP Vitalife Partners (Israel) II, L.P., 10% Owner at Recro Pharma, Inc. (REPH), sold 3,803 shares at $9.00 ($34K) on 2015-11-25, disclosed to the SEC on 2015-11-30.
Open-market sale of $34k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.00 | 1,553 | $14K | 40.8% |
| 2 | $9.00 | 2,250 | $20K | 59.2% |
| Total | $9.00 avg | 3,803 | $34K | 100% |
| Filing → |
| REPH | SELL | 2018-01-08 | $14K | — | Filing → |
| REPH | SELL | 2018-01-04 | $230K | — | Filing → |
| REPH | SELL | 2018-01-02 | $56K | — | Filing → |